A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
On Jan. 1, North Dakota became the first state in the country where access to drugs like Wegovy is part of the EHB package. About 55,293 of North Dakota's 784,000 residents had coverage through fully ...
Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...
Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...
Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback